# FDA 483 - L'Oreal USA Products Inc - February 15, 2024

Source: https://www.globalkeysolutions.net/records/483/loreal-usa-products-inc/c0c250ef-330c-4de9-83bb-35c7478f8627

> FDA 483 for L'Oreal USA Products Inc on February 15, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: L'Oreal USA Products Inc
- Inspection Date: 2024-02-15
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: An FDA inspection of L'Oreal USA Products Inc in Somerset, NJ, identified one observation related to the firm's quality control unit. The observation noted that finished goods testing documentation, including for CeraVe Skin Renewing Day Cream SPF30, was recorded on uncontrolled papers lacking dates, traceability, and QC review. This indicates a failure to fully follow established procedures for record control.

## Related Documents

- [483 - 2012-12-04](https://www.globalkeysolutions.net/records/483/loreal-usa-products-inc/f3fce4d8-c98d-487b-8b0f-2ad6ef280ee2)

## Related Officers

- [Pharmacist | Consumer Safety Officer](https://www.globalkeysolutions.net/people/victoria-spivak/b43d066f-35c1-4d83-9d38-3ba64d77cf31)

Company: https://www.globalkeysolutions.net/companies/loreal-usa-products-inc/33ada4a1-f786-4ea0-aba2-4e25302c5cb9

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248